Go to London Stock Exchange Group Website

GSK  GLAXOSMITHKLINE PLC  ORD 25P

GLAXOSMITHKLINE  Currency GBX  Primary Listed Share

Company

Price +/- % +/- Bid Offer Volume High Low Last close
1,219.50 +0.50 +0.04% 1,219.00 1,220.00 8,031,099 1,227.05 1,217.12 1,219.00 on 08-Feb-2010
As at 09-Feb-2010 14:41:28 - All data delayed by at least 15 minutes.
This company is quoted on  Market

Share price performance

Last 5 trades
Time/Date Price Volume Trade value Type
14:41:22 1,219.50 13 158.54 AT
14:41:13 1,219.88 278 3,391.25 O
14:41:20 1,219.50 16 195.12 AT
14:41:19 1,219.50 468 5,707.26 AT
14:41:19 1,219.50 316 3,853.62 AT

Trading Information
09-Feb-2010
FTSE index FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SET0
MiFID Status
Exchange market size 4,000
SEDOL 0925288
ISIN number GB0009252882


Company Fundamentals
More
2009 (£m) 2008 (£m) 2007 (£m) 2006 (£m)
Currency GBP GBP GBP GBP
Total op. expenses -21,078.00 -17,752.00 -15,598.00 -15,724.00
P/L for the financial year 5,531.00 4,602.00 5,214.00 5,389.00
Retained profit/loss 2,528.00 1,673.00 2,421.00 2,791.00
Total assets 42,862.00 39,393.00 31,003.00 25,553.00
Total liabilities -42,862.00 -39,393.00 -31,003.00 -25,553.00

Latest news stories
More
Time/Date Headline
12:03 09-Feb-10    Director/PDMR Shareholding
17:27 05-Feb-10    Director/PDMR Shareholding
16:32 05-Feb-10    Director/PDMR Shareholding
16:27 04-Feb-10    GSK amends emerging market data in 2009 results
12:00 04-Feb-10    Final Results

Company Information
Updated Monthly
Company address C8 Gsk House, 980 Great West Road, Brentford, TW8 9GS, United Kingdom
Company website http://www.gsk.com
Market cap(in millions)* £ 63,282.04
Listing/Admission to trading 22 May 1972
Trading system
Market MAINMARKET
Activities A group engaged in the creation; discovery; development; manufacture and marketing of pharmaceutical and consumer health-related products
Auditor PricewaterhouseCoopers LLP
Financial Advisor Goldman Sachs International, Morgan Stanley
Broker RBS Hoare Govett Ltd, UBS
Solicitor Slaughter and May
Registrar Equiniti Ltd

*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are subject to change. Last updated: 08-Feb-2010



GLAXOSMITHKLINE price